PT092 - REASSURE observational study of radium-223 (Ra-223): First interim results by prior/concomitant treatment (Tx) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) enrolled in Europe.

Authors :: Logue, J.
Schostak, M.
Baldari, S.
Schrijvers, D.
Sandzén, J.
Meidahl Petersen, P.
Procopio, G.
Strauß, A.
Borrega, P.
Rebmann, U.
Miller, K.
Kalinovský, J.
De Sanctis, Y.
Sternberg, C.
Tombal, B.
Source :: European Urology Supplements. Mar2018, Vol. 17 Issue 2, pe1855-e1856. 1p.
Publication Year :: 2018

Full Text Access

Tools